幕上性与幕下性NF2突变型脑膜瘤的临床与基因组差异
该研究分析了191例散发性NF2突变型脑膜瘤(幕上165例、幕下26例)的临床与全外显子测序数据,发现幕上肿瘤与瘤周水肿、高级别、Ki-67升高、体积更大及染色体1p缺失等更具侵袭性的特征相关;幕下肿瘤次全切除率更高,但总体生存与无进展生存无显著差异。
要点
- 幕上NF2突变型脑膜瘤更常伴水肿(64.0% vs 28.0%,p<0.001)和WHO II/III级(41.8% vs 3.9%,p<0.001)。
- 幕上肿瘤Ki-67升高比例更高(55.0% vs 13.6%,p<0.001),平均体积更大(45.5 cm3 vs 14.9 cm3,p<0.001)。
- 幕下肿瘤次全切除率更高(37.5% vs 15.8%,p=0.021),但总体生存(p=0.2)与无进展生存(p=0.4)无显著差异。
核心结论
- 幕上NF2突变型脑膜瘤相比幕下 counterparts 与更具侵袭性的临床和基因组特征相关,幕下肿瘤次全切除率更高但生存或复发无相关差异,这些发现有助于根据位置指导手术决策和术后管理。
研究设计与样本
- 回顾性分析接受手术切除的散发性NF2突变型脑膜瘤患者的临床与全外显子测序(WES)数据,共纳入191例(幕上165例、幕下26例)。
主要发现
- 幕上NF2突变型脑膜瘤与水肿显著相关(64.0% vs 28.0%,p<0.001)。
- 幕上肿瘤WHO II或III级比例更高(41.8% vs 3.9%,p<0.001),Ki-67升高比例更高(55.0% vs 13.6%,p<0.001)。
- 幕上肿瘤平均体积更大(45.5 cm3 vs 14.9 cm3,p<0.001)。
- 幕上肿瘤更常携带染色体1p缺失(p=0.038),且杂合性缺失导致的基因组改变比例更大(p<0.001)。
- 幕下肿瘤次全切除率高于幕上肿瘤(37.5% vs 15.8%,p=0.021),但总体生存(p=0.2)与无进展生存(p=0.4)无显著差异。
临床怎么用
- 作者认为这些发现有助于根据肿瘤位置更好地指导NF2突变型脑膜瘤的手术决策,并可能指导术后管理。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Mutations in NF2 are the most common somatic driver mutation in sporadic meningiomas. NF2 mutant meningiomas preferentially arise along the cerebral convexities-however, they can also be found in the posterior fossa. The authors investigated whether NF2 mutant meningiomas differ in clinical and genomic features based on their location relative to the tentorium. METHODS: Clinical and whole exome sequencing (WES) data for patients who underwent resection of sporadic NF2 mutant meningiomas were reviewed and analyzed. RESULTS: A total of 191 NF2 mutant meningiomas were included (165 supratentorial, 26 infratentorial). Supratentorial NF2 mutant meningiomas were significantly associated with edema (64.0% vs 28.0%, p < 0.001); higher grade-i.e., WHO grade II or III (41.8% vs 3.9%, p < 0.001); elevated Ki-67 (55.0% vs 13.6%, p < 0.001); and larger volume (mean 45.5 cm3 vs 14.9 cm3, p < 0.001). Furthermore, supratentorial tumors were more likely to harbor the higher-risk feature of chromosome 1p deletion (p = 0.038) and had a larger fraction of the genome altered with loss of heterozygosity (p < 0.001). Infratentorial meningiomas were more likely to undergo subtotal resection than supratentorial tumors (37.5% vs 15.8%, p = 0.021); however, there was no significant difference in overall (p = 0.2) or progression-free (p = 0.4) survival. CONCLUSIONS: Supratentorial NF2 mutant meningiomas are associated with more aggressive clinical and genomic features as compared with their infratentorial counterparts. Although infratentorial tumors have higher rates of subtotal resection, there is no associated difference in survival or recurrence. These findings help to better inform surgical decision-making in the management of NF2 mutant meningiomas based on location, and may guide postoperative management of these tumors.
引用
- Tabor JK, O'Brien J, Vasandani S, et al. Clinical and genomic differences in supratentorial versus infratentorial NF2 mutant meningiomas. J Neurosurg. 2023. PMID: 37243548. doi:10.3171/2023.4.JNS222929
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。